menu
    • menu
    [{"orgOrder":0,"company":"China National Center for Cardiovascular Diseases","sponsor":"Tibet Kang Zhe Pharmaceutical Technology Co., Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"CHINA","productType":"Peptide, Unconjugated","year":"2017","type":"Inapplicable","leadProduct":"Natriuretic Peptide, Brain","moa":"Atrial natriuretic peptide receptor A","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"China National Center for Cardiovascular Diseases","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"China National Center for Cardiovascular Diseases \/ Tibet Kang Zhe Pharmaceutical Technology Co., Ltd","highestDevelopmentStatusID":"1","companyTruncated":"China National Center for Cardiovascular Diseases \/ Tibet Kang Zhe Pharmaceutical Technology Co., Ltd"}]

    Find Clinical Drug Pipeline Developments & Deals for Natriuretic Peptide, Brain

    Menu

    Natriuretic Peptide, Brain

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            China National Center for Cardiovascular Diseases

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            China National Center for Cardiovascular Diseases

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Natriuretic Peptide, Brain

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : Tibet Kang Zhe Pharmaceutical Technology Co., Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children

                            Details : Nesiritide is a Peptide drug candidate, which is currently being evaluated in clinical studies for the treatment of Heart Defects, Congenital.

                            Product Name : Undisclosed

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Inapplicable

                            July 02, 2017

                            Lead Product(s) : Natriuretic Peptide, Brain

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Tibet Kang Zhe Pharmaceutical Technology Co., Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth